Literature DB >> 25081286

Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.

H W Chung1, C M Yun2, J T Kim3, S-W Kim2, J Oh2, K Huh2.   

Abstract

PURPOSE: To investigate the relationship between retinal sensitivity (RS) assessed by microperimetry (MP) and retinal structural changes in patients with resolved central serous chorioretinopathy (CSC).
METHODS: Spectral domain optical coherence tomography (OCT) examination and MP tests were performed in patients with resolved CSC. Point-to-point correlation was performed between RS and corresponding retinal structural changes using Pearson's correlation analysis. In addition, in a 1-mm zone in the central fovea, a correlation was calculated between the mean RS and the mean central retinal thickness (CRT).
RESULTS: Eighty-four eyes were analyzed. The total number of MP test points was 1092 (84 eyes × 13 points). The mean RS and retinal point thickness (RPT) of all test points were 13.53±3.84 dB and 208.6±48.0 μm, respectively. The RS and RPT were significantly decreased in the test points with loss of the ellipsoid portion of the inner segments (EPIS) (P<0.0001). Within the 1-mm foveal center zone, there was a significant correlation between mean RS and mean CRT (r=0.432, P<0.0001) and between RS and the corresponding RPT (r=0.339, P<0.0001).
CONCLUSION: RS was dependent on the status of the EPIS in patients with resolved CSC. The correlation between mean RS and mean CRT was compatible with the point-to-point correlation between RS and the corresponding RPT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081286      PMCID: PMC4194344          DOI: 10.1038/eye.2014.185

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  30 in total

1.  Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.

Authors:  Kyoko Fujita; Mitsuko Yuzawa; Ryusaburou Mori
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

2.  Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Kyoko Fujita; Kei Shinoda; Yutaka Imamura; Celso Soiti Matsumoto; Yoshihiro Mizutani; Atsushi Mizota; Mitsuko Yuzawa
Journal:  Am J Ophthalmol       Date:  2012-07-20       Impact factor: 5.258

3.  Correlations among various functional and morphological tests in resolved central serous chorioretinopathy.

Authors:  Seong-Woo Kim; Jaeryung Oh; Kuhl Huh
Journal:  Br J Ophthalmol       Date:  2011-05-26       Impact factor: 4.638

4.  Visual function following photodynamic therapy for central serous chorioretinopathy: a comparison of automated macular microperimetry versus best-corrected visual acuity.

Authors:  Rita Ehrlich; Nick P Mawer; Christopher H Mody; Christopher S Brand; David Squirrell
Journal:  Clin Exp Ophthalmol       Date:  2011-09-19       Impact factor: 4.207

5.  Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy.

Authors:  Seong-Woo Kim; Jaeryung Oh; Soon-Sun Kwon; Junho Yoo; Kuhl Huh
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

6.  Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Helena Vasconcelos; Inês Marques; A Rita Santos; Pedro Melo; Isabel Pires; João Figueira; José Faria de Abreu; M Luz Cachulo; Rufino Silva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

7.  Indocyanine green angiographic findings in central serous chorioretinopathy.

Authors:  C Prünte
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

8.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

9.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

10.  [Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects].

Authors:  H C Gäckle; G E Lang; K A Freissler; G K Lang
Journal:  Ophthalmologe       Date:  1998-08       Impact factor: 1.059

View more
  5 in total

1.  The association between visual function and retinal structure in chronic central serous chorioretinopathy.

Authors:  Aya Sugiura; Ryosuke Fujino; Nobuko Takemiya; Kimiko Shimizu; Masato Matsuura; Hiroshi Murata; Tatsuya Inoue; Ryo Obata; Ryo Asaoka
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

2.  Association between visual function and the integrity of residual ellipsoid zone in resolved central serous chorioretinopathy.

Authors:  Asahi Fujita; Yurika Aoyama; Saori Tsuneyoshi; Aya Sugiura; Keiko Azuma; Kimiko Asano-Shimizu; Hirotsugu Soga; Yohei Hashimoto; Ryo Asaoka; Tatsuya Inoue; Ryo Obata
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

3.  Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.

Authors:  Takehito Iwase; Hirotaka Yokouchi; Masayasu Kitahashi; Mariko Kubota-Taniai; Takayuki Baba; Shuichi Yamamoto
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

4.  The Relationship Between Visual Sensitivity and Eccentricity, Cone Density and Outer Segment Length in the Human Foveola.

Authors:  Niklas Domdei; Jenny L Reiniger; Frank G Holz; Wolf M Harmening
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

5.  Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.

Authors:  Seungbum Kang; Young Gun Park; Jae Ryun Kim; Eric Seifert; Dirk Theisen-Kunde; Ralf Brinkmann; Young Jung Roh
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.